Exclusive

Publication

Byline

Location

US Patent Issued to GlaxoSmithKline Intellectual Property (No.3) on Sept. 15 for "Compositions and methods for treatment of hepatitis D virus infection" (Belgian, American, German Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,699, issued on Sept. 15, was assigned to GlaxoSmithKline Intellectual Property (No.3) Ltd. (Stevenage, Great Britain). "Compositions and m... Read More


US Patent Issued to Ionis Pharmaceuticals on Sept. 15 for "Compounds and methods for reducing FUS expression" (California Inventor)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,700, issued on Sept. 15, was assigned to Ionis Pharmaceuticals Inc. (Carlsbad, Calif.). "Compounds and methods for reducing FUS expression... Read More


US Patent Issued to Rznomics on Sept. 15 for "Trans-splicing ribozyme specific to ApoE4 RNA and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,701, issued on Sept. 15, was assigned to Rznomics Inc. (Yongin-si, South Korea). "Trans-splicing ribozyme specific to ApoE4 RNA and use th... Read More


US Patent Issued to ALNYLAM PHARMACEUTICALS on Sept. 15 for "Endosomal cleavable linkers" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,702, issued on Sept. 15, was assigned to ALNYLAM PHARMACEUTICALS INC. (Cambridge, Mass.). "Endosomal cleavable linkers" was invented by Ja... Read More


US Patent Issued to WAVE LIFE SCIENCES on Sept. 15 for "Oligonucleotide compositions and methods of use thereof" (Massachusetts, Pennsylvania Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,703, issued on Sept. 15, was assigned to WAVE LIFE SCIENCES LTD. (Singapore). "Oligonucleotide compositions and methods of use thereof" wa... Read More


US Patent Issued to DONG-A UNIVERSITY RESEARCH FOUNDATION FOR INDUSTRY-ACADEMY COOPERATION on Sept. 15 for "Anticancer adjuvant and pharmaceutical composition for treating anticancer-agent-resistant cancer, and kit comprising same" (South Korean Inventor)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,704, issued on Sept. 15, was assigned to DONG-A UNIVERSITY RESEARCH FOUNDATION FOR INDUSTRY-ACADEMY COOPERATION (Busan, South Korea). "Ant... Read More


US Patent Issued to The General Hospital on Sept. 15 for "ABCD1 for treatment of neurodisorders" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,706, issued on Sept. 15, was assigned to The General Hospital Corp. (Boston). "ABCD1 for treatment of neurodisorders" was invented by Case... Read More


US Patent Issued to Massachusetts Eye and Ear Infirmary on Sept. 15 for "RUNX1 inhibition for treatment of proliferative vitreoretinopathy and conditions associated with epithelial to mesenchymal transition" (Massachusetts, California Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,707, issued on Sept. 15, was assigned to Massachusetts Eye and Ear Infirmary (Boston). "RUNX1 inhibition for treatment of proliferative vi... Read More


US Patent Issued to CHINESE PLA GENERAL HOSPITAL on Sept. 15 for "Engineered exosome for treating hypertrophic scar (HTS), and preparation method and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,708, issued on Sept. 15, was assigned to CHINESE PLA GENERAL HOSPITAL (Beijing). "Engineered exosome for treating hypertrophic scar (HTS),... Read More


US Patent Issued to Sanegene Bio USA on Sept. 15 for "Small interfering RNA targeting CFB and uses thereof" (Massachusetts, Oklahoma Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,709, issued on Sept. 15, was assigned to Sanegene Bio USA Inc. (Woburn, Mass.). "Small interfering RNA targeting CFB and uses thereof" was... Read More